Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems Manufacturer will remove all remaining BioZorb Markers from the market, following adverse events and lawsuits filed by women who experienced problems with the breast tissue implant. October 25, 2024 Irvin Jackson Add Your Comments Federal regulators are warning doctors not to use BioZorb Markers, due to serious adverse events reported among women who had implants placed in breast tissue for targeted cancer treatments. The U.S. Food and Drug Administration (FDA) issued a BioZorb Marker safety communication on October 25, urging physicians to return all unused implants to the manufacturer, Hologic, Inc., and to continue monitoring for health complications among patients who had the device implanted in their breast tissue. The BioZorb Marker is a small implant approved for use among breast cancer survivors and other individuals who require targeted radiation therapy, which consists of a biodegradable spacer made from polylactic acid, and six permanent titanium clips. The implant is designed to gradually break down and dissolve in the body, leaving only the clips in place to aid in the precise marking of previous surgical tumor removal sites. Earlier this year, the FDA announced a smaller BioZorb recall, after the manufacturer sent a safety notification to medical providers indicating that the device may be prone to cause pain, infection, rash, device migration, erosion and other complications. While the manufacturer did not remove BioZorb from the market at that time, the FDA did classify the warning as a Class I medical device recall, suggesting that continued use of the product may cause serious injury or death. In the wake of that earlier announcement, dozens of BioZorb Marker lawsuits have been filed by breast cancer survivors, alleging that the company failed to adequately disclose risks associated with the device to patients and the medical community. However, this week the company has expanded that prior BioZorb recall to remove all unused devices from circulation. BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “This notification is different than the safety notification sent in February,” the manufacturer stated in a press release issued on October 24. “Hologic is now requesting all lots of unused BioZorb Markers to be returned.” The manufacturer indicates that more than 90,000 BioZorb markers have been sold since 2015, and there have been nearly 300 complaints or adverse events reported. Typically only between 1% and 10% of all problems associated with a medical device ever get reported to the company. As a result, Hologic is now instructing medical facilities to quarantine any remaining implants in their inventory, and the company is working closely with the FDA to remove the BioZorb Marker from the market. FDA BioZorb Marker Recommendations For those patients who already have a BioZorb Marker implanted, the FDA indicates they should report any adverse events to their healthcare provider. However, the agency indicates there is no need to have the device removed unless their doctor advises them to do so. In addition, patients with BioZorb Markers are advised to discuss the possible risks if they are planning to receive any radiation treatments, as the FDA has never approved the implant for that purpose. The FDA instructs health care providers and medical facilities to not implant BioZorb Markers, and return all unused products to Hologic. However, doctors should continue to be on the lookout for reports of problems with the implant, and to continue to monitor patients who are still waiting to see if the implant has absorbed successfully into their bodies. The agency indicates that potential signs of problems with a BioZorb Marker may include: Pain Infection Rash Device migration Device erosion Fluid buildup (seroma) Discomfort The ability to feel the device in the breast Patients and doctors who experience BioZorb Marker problems are encouraged to file a report through the FDA’s MedWatch adverse event reporting program. 2024 BioZorb Lawsuit Update The recall comes as Hologic already faces dozens of BioZorb lawsuits being pursued by patients who experienced problems, and it is expected that the decision to remove the implant from the market will have a major impact on the litigation. Nearly all complaints have been filed in the U.S. District Court for the District of Massachusetts, where the manufacturer’s headquarters are located. Given common questions of fact and law raised in the claims, the lawsuits over recalled BioZorb markers have been consolidated before U.S. District Judge Allison D. Burroughs, for coordinated discovery and pretrial proceedings. Earlier this year, Judge Burroughs established a BioZorb lawsuit “bellwether” program, where the parties selected a small group of representative claims to go through pretrial motions and case-specific discovery in preparation for a series of early trial dates, which may begin by July 2025. While the outcome of these first trials will not have any binding impact on other lawsuits, they will be closely watched to gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, and the average lawsuit payout may have a substantial impact on the amounts of BioZorb recall settlements Hologic may be forced to pay in the future. Tags: BioZorb Markers, Breast Cancer, FDA, Medical Device Recall, Medical Implant, Radiation Therapy Find Out If You Qualify for BioZorb Failure Compensation More BioZorb Lawsuit Stories Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker March 26, 2025 Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker March 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)